Thursday, July 02, 2026 | 02:00 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Lupin Ltd Quarterly Results

Q4 FY25-26 Results Summary

Revenue

The revenue stands at ₹7,474.66 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.29 per cent from ₹7,167.52 crore. This corresponds to a year-on-year *(YoY) growth of 31.89 per cent.

Operating Profit

Operating Profit stands at ₹2,354.24 crore, reflecting a quarter-on-quarter *(QoQ) increase of 28.28 per cent from ₹1,835.28 crore. This corresponds to a year-on-year *(YoY) growth of 78.19 per cent.

PBDT

PBDT stands at ₹2,374.79 crore, reflecting a quarter-on-quarter *(QoQ) increase of 29.42 per cent from ₹1,835.00 crore. This corresponds to a year-on-year *(YoY) growth of 84.23 per cent.

Profit Before Tax

Profit Before Tax stands at ₹1,928.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 26.67 per cent from ₹1,522.04 crore. This corresponds to a year-on-year *(YoY) growth of 115.22 per cent.

Net Profit

Net Profit stands at ₹1,468.67 crore, reflecting a quarter-on-quarter *(QoQ) increase of 24.41 per cent from ₹1,180.51 crore. This represents a 87.72 per cent year-on-year *(YoY) growth for the same year.

  • YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.

Lupin Ltd Earnings

Data not available

Lupin Ltd Earning Charts

Revenue from Operations

in ₹ cr

EBITDA

in ₹ cr

Profit before Tax

in ₹ cr

Net Profit

in ₹ cr

Lupin Ltd Research Reports

ActionTarget Price (₹)BrokerDateReports
Buy 2,500Emkay Global16-Feb-2026
Accumulate 2,200Kotak Securities10-Oct-2025
Neutral 2,000Motilal Oswal07-Aug-2025
Accumulate 2,392Elara Capital16-May-2025
Accumulate 2,392Elara Capital11-Nov-2024

Lupin Ltd Financial Reports

Filter By:
Loading...

Lupin Ltd Stock Prices Compare with Peers

Company1 Day1 Week1 month3 month6 month1 Year
Lupin-0.99%-0.47%5.98%5.19%15.30%22.53%
Cipla-0.72%0.28%6.00%21.35%-4.07%-3.38%
Dr Reddy's Labs-1.43%-2.83%5.92%9.88%7.10%3.41%
Zydus Lifesci.-0.30%-1.14%3.01%27.99%20.29%10.95%
Mankind Pharma-2.35%0.20%5.01%23.34%13.53%5.36%
Aurobindo Pharma-1.32%0.40%7.96%16.06%28.79%34.57%
Laurus Labs-1.48%-0.36%7.38%41.48%35.80%97.53%

Company Info

Company Information

Chairman (Non-Executive) : M D Gupta

Managing Director : Nilesh Deshbandhu Gupta.

Director & Chief Executive Officer : Vinita Gupta

Company Sec. & Compli. Officer : R V Satam

Independent Director : Jean-Luc Belingard

Director & Group CFO : Ramesh Swaminathan

Independent Director : Mark D McDade

Independent Director : K B S Anand

Independent Director : Jeffrey Kindler

Independent Director : Alfonso Zulueta

Independent Director : Punita Lal

Lupin Ltd News

Data Not Available